Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma

References

• Acheampong AA, Shackleton M, Tang-Liu DD. (1995). Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits. Drug Metab Dispos 23:708–12.
   PubMed Web of Science ®Google Scholar
• Adams CM, Stacy R, Rangaswamy N, et al. (2019). Glaucoma – next generation therapeutics: impossible to possible. Pharm Res 36:25.
   Web of Science ®Google Scholar
• Adkins JC, Balfour JA. (1998). Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Drugs Aging 12:225–41.
   PubMed Web of Science ®Google Scholar
• Alvarez-Rivera F, Concheiro A, Alvarez-Lorenzo C. (2018). Epalrestat-loaded silicone hydrogels as contact lenses to address diabetic-eye complications. Eur J Pharm Biopharm 122:126–36.
   PubMed Web of Science ®Google Scholar
• Aref AA. (2017). Sustained drug delivery for glaucoma: current data and future trends. Curr Opin Ophthalmol 28:169–74.
   PubMed Web of Science ®Google Scholar
• Bertens CJF, Gijs M, Dias AAJ, et al. (2021). Pharmacokinetics and efficacy of a ketorolac-loaded ocular coil in New Zealand white rabbits. Drug Deliv 28:400–7.
   PubMed Web of Science ®Google Scholar
• Brandt JD, Sall K, DuBiner H, et al. (2016). Six-month intraocular pressure reduction with a topical bimatoprost ocular insert: results of a phase II randomized controlled study. Ophthalmology 123:1685–94.
   PubMed Web of Science ®Google Scholar
• Chiang B, Kim YC, Doty AC, et al. (2016). Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma. J Control Release 228:48–57.
   PubMed Web of Science ®Google Scholar
• Cho IS, Park CG, Huh BK, et al. (2016). Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy. Acta Biomater 39:124–32.
   PubMed Web of Science ®Google Scholar
• Chou SF, Luo LJ, Lai JY. (2016). Gallic acid grafting effect on delivery performance and antiglaucoma efficacy of antioxidant-functionalized intracameral pilocarpine carriers. Acta Biomater 38:116–28.
   PubMed Web of Science ®Google Scholar
• De TK, Rodman DJ, Holm BA, et al. (2003). Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery. J Microencapsul 20:361–74.
   PubMed Web of Science ®Google Scholar
• Eldeeb AE, Salah S, Ghorab M. (2019). Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv 26:509–21.
   PubMed Web of Science ®Google Scholar
• El-Salamouni NS, Farid RM, El-Kamel AH, El-Gamal SS. (2015). Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Int J Pharm 496:976–83.
   PubMed Web of Science ®Google Scholar
• Fenton OS, Olafson KN, Pillai PS, et al. (2018). Advances in biomaterials for drug delivery. Adv Mater 30:1705328.
   Web of Science ®Google Scholar
• Folkman J, Long DM. (1964). The use of silicone rubber as a carrier for prolonged drug therapy. J Surg Res 4:139–42.
   PubMed Web of Science ®Google Scholar
• Ghate D, Edelhauser HF. (2008). Barriers to glaucoma drug delivery. J Glaucoma 17:147–56.
   PubMed Web of Science ®Google Scholar
• Hosoya K, Lee VHL, Kim KJ. (2005). Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm 60:227–40.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM, Abd-Elgawad AH, Soliman OA, Jablonski MM. (2015). Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma. Transl Vis Sci Technol 4:12.
   PubMed Web of Science ®Google Scholar
• Jain N, Verma A, Jain N. (2020). Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white Albino rabbits. Drug Deliv 27:888–99.
   PubMed Web of Science ®Google Scholar
• Kim KE, Jang I, Moon H, et al. (2015). Neuroprotective effects of human serum albumin nanoparticles loaded with brimonidine on retinal ganglion cells in optic nerve crush model. Invest Ophthalmol Vis Sci 56:5641–9.
   PubMed Web of Science ®Google Scholar
• Lai JY, Hsieh AC. (2012). A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine. Biomaterials 33:2372–87.
   PubMed Web of Science ®Google Scholar
• Lai JY, Luo LJ, Nguyen DD. (2020). Multifunctional glutathione-dependent hydrogel eye drops with enhanced drug bioavailability for glaucoma therapy. Chem Eng J 402:126190.
   Web of Science ®Google Scholar
• Li T, Lindsley K, Rouse B, et al. (2016). Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 123:129–40.
   PubMed Web of Science ®Google Scholar
• Li TT, Wang Y, Chen JH, et al. (2020). Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy. Drug Deliv 27:410–21.
   PubMed Web of Science ®Google Scholar
• Lin TW, Chien Y, Lin YY, et al. (2019). Establishing liposome-immobilized dexamethasone-releasing PDMS membrane for the cultivation of retinal pigment epithelial cells and suppression of neovascularization. Int J Mol Sci 20:241.
   PubMed Web of Science ®Google Scholar
• Liu J, Yao Y, Li XH, Zhang ZJ. (2021). Fabrication of advanced polydimethylsiloxane-based functional materials: bulk modifications and surface functionalizations. Chem Eng J 408:127262.
   Web of Science ®Google Scholar
• Luo LJ, Nguyen DD, Lai JY. (2021). Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. Theranostics 11:5447–63.
   PubMed Web of Science ®Google Scholar
• Maiti S, Paul S, Mondol R, et al. (2011). Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation. AAPS PharmSciTech 12:755–63.
   PubMed Web of Science ®Google Scholar
• Malcolm RK, Boyd PJ, McCoy CF, Murphy DJ. (2016). Microbicide vaginal rings: technological challenges and clinical development. Adv Drug Deliv Rev 103:33–56.
   PubMed Web of Science ®Google Scholar
• Mealy JE, Fedorchak MV, Little SR. (2014). In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate. Acta Biomater 10:87–93.
   PubMed Web of Science ®Google Scholar
• Musgrave CSA, Fang FZ. (2019). Contact lens materials: a materials science perspective. Materials 12:261.
   PubMed Web of Science ®Google Scholar
• Nguyen DD, Lai JY. (2020). Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment. Polym Chem 11:6988–7008.
   Web of Science ®Google Scholar
• Nguyen DD, Luo LJ, Lai JY. (2020). Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma. Acta Biomater 111:302–15.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Lashkari K, Hirose T, et al. (2001). Erosion and intrusion of silicone rubber scleral buckle. presentation and management. Retina 21:214–20.
   PubMed Web of Science ®Google Scholar
• Nordstrom BL, Friedman DS, Mozaffari E, et al. (2005). Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140:598–606.
   PubMed Web of Science ®Google Scholar
• Pang XC, Li JW, Pi JX, et al. (2018). Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits. Pharm Dev Technol 23:231–9.
   PubMed Web of Science ®Google Scholar
• Ravindran VK, Repala S, Subadhra S, Appapurapu AK. (2014). Chick chorioallantoic membrane model for in ovo evaluation of timolol maleate-brimonidine tartrate ocular inserts. Drug Deliv 21:307–14.
   PubMed Web of Science ®Google Scholar
• Reardon G, Kotak S, Schwartz GF. (2011). Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence 5:441–63.
   PubMed Web of Science ®Google Scholar
• Rubiao F, Araujo ACF, Sancio JB, et al. (2021). Topical bimatoprost insert for primary open-angle glaucoma and ocular hypertension treatment – a phase II controlled study. Curr Drug Deliv 18:1010–4.
   Web of Science ®Google Scholar
• Singh KH, Shinde UA. (2011). Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane. Pharmazie 66:594–9.
   PubMed Web of Science ®Google Scholar
• Sun JG, Lei Y, Dai ZX, et al. (2017). Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma. ACS Appl Mater Interfaces 9:7990–9.
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, et al. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–90.
   PubMed Web of Science ®Google Scholar
• Tsukimura N, Yamada M, Aita H, et al. (2009). N-acetyl cysteine (NAC)-mediated detoxification and functionalization of poly(methyl methacrylate) bone cement. Biomaterials 30:3378–89.
   PubMed Web of Science ®Google Scholar
• Xiang K, Huang G, Zheng J, et al. (2012). Accelerated thermal ageing studies of polydimethylsiloxane (PDMS) rubber. J Polym Res 19:9869.
   Web of Science ®Google Scholar
• Yan F, Liu YX, Han SL, et al. (2020). Bimatoprost imprinted silicone contact lens to treat glaucoma. AAPS PharmSciTech 21:63.
   PubMed Web of Science ®Google Scholar
• Yang H, Tyagi P, Kadam RS, et al. (2012). Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration. ACS Nano 6:7595–606.
   PubMed Web of Science ®Google Scholar
• Zargar R, Nourmohammadi J, Amoabediny G. (2016). Preparation, characterization, and silanization of 3D microporous PDMS structure with properly sized pores for endothelial cell culture. Biotechnol Appl Biochem 63:190–9.
   PubMed Web of Science ®Google Scholar
• Zheng PF, You QS, Li Q, et al. (2018). Injectable silicone rubber for ocular implantation after evisceration. PLOS One 13:e0193448.
   PubMed Web of Science ®Google Scholar